Mycoses

Article	Citations
Author Index	58
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	50
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	49
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	48
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	47
	46
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	42
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	41
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	40
Physicians' knowledge of invasive fungal disease in China	39
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	36
Issue Information	34
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	33
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	33
Emergence of Candida auris in intensive care units in Algeria	33
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	31
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	31
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	31
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	29
Review Article White Piedra: Review of 131 cases	28
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	28
Issue Information	28
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	26
Issue Information	25
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	25

Issue Information	24
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	24
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	23
Issue Information	21
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	21
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	21
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	21
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	21
	21
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	21
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	20
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	20
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	19
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	19
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	19
Cover Image	19
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	19
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	18
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	18
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	18
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	17
Diagnostic performance of noncultural methods for central nervous system aspergillosis	17
Tinea pedis in underrepresented groups: All of Us database analysis	17
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	17
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	17
	16
	16
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	16
	16
CARD9 mutations in patients with fungal infections: An update from the last 5 years	16
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial	16
	15
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	15
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	15
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	15
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	15
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	14
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	14
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	14
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	14
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	13
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	13
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	13
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	13
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	13
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	13
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	13
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	13

Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	13
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	12
	12
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	12
	12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	12
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	12
Issue Information	12
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	12
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	12
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	11
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	11
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	11
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	11
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	11
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	11
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	11
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	11
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	10
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	10
	10
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	10
Aspergillus nodules: Natural history and the effect of antifungals	10
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	10
Issue Information	10
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	10
	10
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	10
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Expert recommendations for prevention and management of Candida auris transmission	9
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	9
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
	9
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	9
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	9
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Abstracts	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Updated estimation of the burden of fungal disease in Vietnam	8
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Issue Information	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Time and cost‐efficient identification of Trichophyton indotineae	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
Issue Information	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Invasive fungal infections in acute and chronic liver impairment: A systematic review	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7
	7

Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	6
Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytesITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen	6
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	6
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	6
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	6
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	6
	6
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	6
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	6
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	6
Issue Information	6
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	6
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	6
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	6
Issue Information	6
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran	6
	6
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	6
Altered skin fungal and bacterial community compositions in tinea capitis	6
Deep Learning Models for CT Segmentation of Invasive Pulmonary Aspergillosis, Mucormycosis, Bacterial Pneumonia and Tuberculosis: A Multicentre Study	6
Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population‐Based Cohort	6
Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	6
The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergil	5
Issue Information	5
Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study	5
Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection	5
Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis	5
Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients	5
Hyperthermia is a promising potential adjunct to treating sporotrichosis: A refractory case of HIV sporotrichosis and in vitro experiments on Sporothrix spp.	5
Issue Information	5
Comparison of features and outcomes between HIV‐negative patients with Cryptococcus gattii meningitis and Cryptococcus neoformans meningitis in South China	5
Antifungal susceptibility of the clinical and environmental strains of Cryptococcus gattii sensu lato in Taiwan	5
Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response	5
	5
In memoriam: Professor Dieter Buchheidt, MD, PhD, FECMM (1955‐2021)	5
	5
Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples	5
Effect of Antifungal Therapy on the Postoperative Period in Non‐Invasive Fungal Sinusitis: A Systematic Review and Meta‐Analysis	5
Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19	5
Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016–2022) and Literature Review From Pakistan	5
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients	5
Issue Information	5
Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non‐HIV Cryptococcal meningitis: A nationwide observational study	5
Role of recombinant Histoplasma capsulatum 100‐kilodalton antigen in the diagnosis of histoplasmosis among HIV/AIDS patients: Antigenuria and antibodies detection	5
Issue Information	5
The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single‐centre study	5
The Effect of Topical Ketoconazole and Topical Miconazole Nitrate in Modulating the Skin Microbiome and Mycobiome of Patients With Tinea Pedis	5
Cytomegalovirus viral interleukin‐10 in patients with Aspergillus infection and effects on clinical outcome	5
Supervised training models with or without manual lesion delineation outperform clinicians in distinguishing pulmonary cryptococcosis from lung adenocarcinoma on chest CT	5
Potential emergence of terbinafine resistance by squalene epoxidase gene mutations: An 18‐month cohort study of onychomycosis patients in the United States	5
Application of deep learning algorithm in the recognition of cryptococcosis and talaromycosis skin lesions	5
Incidence of Coronavirus Disease 2019‐Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review	5
In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs	5
Rapid detection of dermatophytes using the Seegene Novaplex™ dermatophyte assay	5
Pharmacies Counselling of Patients in the Era of Antifungal Resistance	5
Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critica	5
Terbinafine Resistance in Trichophyton Species From Patients With Recalcitrant Infections Detected by the EUCAST Broth Microdilution Method and DermaGenius Resistance Mult	5
Erratum	5
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India	5
Aetiology of tinea of vellus hair and substrate specificity in Microsporum species	5
Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis	4
Fungal Skin Disease Incidence, Prevalence and Disability‐Adjusted Life Years in Four Asian Countries (1990–2019)	4
Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020	4
Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China	4
What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature	4
Clinical Characteristics and Genomic Analysis of a Trichophyton indotineae Strain Resistant to Terbinafine and Fluconazole Isolated in Italy	4
Issue Information	4
Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single‐centre cohort study	4
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses	4
Green natural nail polish modified with essential oils to treat onychomycosis	4
Inopinatus corneliae sp. nov. gen. nov. isolated from human skin: A newly discovered keratinophilic hyphomycete, order Onygenales	4
Development and Validation of an Explainable Machine Learning Model for Predicting Invasive Fungal Infection in Acute‐On‐Chronic Liver Failure Within 28 Days	4
Evaluation of Currently Available Laboratory Methods to Detect Terbinafine Resistant Dermatophytes Including a Gradient Strip for Terbinafine, EUCAST Microdilution E.Def 11.0, a Commercial	4
Nikkomycin Z for the treatment of experimental sporotrichosis caused bySporothrix brasiliensis	4
	4
Clinical and Hospital Environmental Fusarium in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Phylogenetic Analyses	4
Is Antifungal Prophylaxis Needed for Acute Myeloid Leukaemia Patients Treated With Venetoclax‐Based Regimens? A Systematic Review and Meta‐Analysis	4
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B	4
Ex Vivo Fungal Nail Penetration Study: Effects of Causative Organisms, Nail Polish and Age	4
Effect of the implementation of clinical guidelines on management of candidemia in elderly patients	4
Antifungal use via outpatient parenteral antimicrobial therapy	4
	4
Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland	4
	4
Understanding Global Access to Topical Onychomycosis Therapy: A Systematic Review and Meta‐Analysis	4
Continuous dosing of nikkomycin Z against systemic candidiasis, in vivo and in vitro correlates	4
Exome Sequencing of a Blastomycosis Case–Control Cohort From Manitoba and Northwestern Ontario, Canada	4
‘CT and CT image‐based texture image analysis in radiological diagnostics of allergic fungal rhinosinusitis’	4
Disease burden and demographic characteristics of mucormycosis: A nationwide population‐based study in Taiwan, 2006–2017	4
Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021	4
Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis	4
Utility of MALDI‐ToF MS for Recognition and Antifungal Susceptibility of Nannizzia, an Underestimated Group of Dermatophytes	4
South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature	4
Multi‐state evaluation of Candida infections in burn patients	4